Home biotech
 

Keywords :   


Tag: biotech

Premarket Biotech Digest: Valeant's Woes, Galmed's Potential, Five Prime's Rally

2015-10-16 23:30:33| Biotech - Topix.net

We had Turing doing that and it got targeted, and in today's digest, we have Valeant getting two federal subpeonas. The stock fell 26% this month.

Tags: potential digest rally biotech

 

FDA to Host First Public Meeting on Biotech Regulation Overhaul

2015-10-16 19:10:33| Biotech - Topix.net

On October 15, 2015, the Food and Drug Administration posted notice of a public meeting to be held on Friday October 30th, in order to clarify the current roles and responsibilities described in the Coordinated Framework for the Regulation of Biotechnology and to develop a long-term strategy for the regulation of the products of biotechnology. The meeting notice follows the White House's Office of Science and Technology Policy's July 2015 memorandum announcing a major overhaul of the current biotech regulatory framework.

Tags: public meeting host regulation

 
 

Premarket Biotech Digest: Democrats Debate Biotech, Anavex Rally, Johnson & Johnson Results

2015-10-14 20:14:21| Biotech - Topix.net

That is what was said at the Democratic debate at Las Vegas yesterday, in which Hillary Clinton, Bernie Sanders and other democratic candidates took part. In some form or other, a debate just like this rages across every large country in the world.

Tags: results johnson debate digest

 

The First Cancer ETF Tracks the Hottest Area of Biotech

2015-10-14 16:12:20| Biotech - Topix.net

Launching a biotech exchange-traded fund after a big selloff in the sector isn't the best timing. But Brad Loncar, a popular biotech blogger and investor, hopes people will be intrigued by the very specific and very hot slice of the biotech sector his new ETF focuses on - cancer immunotherapies.

Tags: area cancer tracks hottest

 

Alimera Sciences: Insiders Buying This Biotech, Stock Sees Catalyst

2015-10-13 08:51:01| Biotech - Topix.net

Alimera Sciences is a bio-pharmaceutical company on the Nasdaq with a market cap of $116 million. The company has developed a product called Iluvien , which was FDA approved in 2014 and made commercially available in the US, UK, Germany and Portugal.

Tags: stock buying sciences sees

 

Sites : [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] next »